openPR Logo
Press release

Asia Pacific Cancer Screening Market Projected to Reach US$32.26 Billion at 17.3% CAGR Till 2023 | Key Players - Abbott diagnostics, GE healthcare, Hologic, Siemens, Thermo Fisher Scientific

01-08-2019 04:44 AM CET | Health & Medicine

Press release from: Business Industry Reports

Cancer Screening Market

Cancer Screening Market

A fresh report has been added to the wide database of Business Industry Reports. The research study is titled “Cancer Screening Market” by Manufacturers, Countries, Type and Application, Forecast to 2023 which provides important data about the production, consumption, revenue and company profiles for key industry participants.

Asia Pacific Cancer Screening Market Synopsis:

According to Market Analyst, The Asia Pacific Cancer Screening Market is forecasted to grow at a compound annual growth rate (CAGR) of 17.3% resulting in annual revenue of USD 32.26 Bn during the forecast period (2018-2023).

Get Free Sample Study Papers of “Cancer Screening Market” @ https://www.businessindustryreports.com/sample-request/122745 .

Asia-Pacific is a rapidly growing cancer market. Asia Pacific is rapidly adopting the latest technological developments and is contributing towards exhaustive research initiatives to contribute to the growth of the cancer screening market.

Cancer Screening Market can be segmented on the Basis of screening type, application type, end users and countries. On the Basis of screening type, the market is segmented into laboratory, genetic, imaging, biopsy and endoscopy tests. Genetic, biopsy and endoscopy will be the leading segments during the forecast period 2018-2023.

Based on Application Type, the market can be segmented into lung, breast, melanoma, kidney and colorectal cancer types. Colorectal, kidney, melanoma and breast cancer will occupy a larger share of the market during the forecast period 2018-2023. Furthermore, Based on end users, the market is segmented into hospitals, laboratories, and independent physicians and clinics. Laboratories segment will witness a progressive growth during the forecast period 2018-2023 while the hospital segment will account for the maximum revenue of USD 11.18 Bn during the forecast period.

Based on Countries, the market is divided into India, China and the rest of Asia-Pacific. The growing patient pool in India, China and Japan due to the support in diagnostic process at comparatively lower prices, and a favorable regulatory framework are some of the factors boosting the market growth in this region.

Complete report on Cancer Screening Market spread across 90 Pages and No. of Table of contents. Buy Research at https://www.businessindustryreports.com/buy-now/122745/single .

The Market is segmented and projected on the basis of major key player’s:

1 Abbott diagnostics

2 GE healthcare

3 Hologic Inc

4 Siemens Healthcare GmbH

5 Thermo Fisher Scientific Inc.

Market segment by Regions/Countries, this report covers:

1 India

2 China

3 Japan

Request a Discount on standard prices of this premium report at https://www.businessindustryreports.com/check-discount/122745 .

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Key Questions Answered in this Report:

1 What will the market size be in 2023?

2 What is driving this market??

3 What are the challenges to market growth?

4 Who are the key players in Cancer Screening Market?

5 What are the market opportunities and threats faced by the key players?

TABLE OF CONTENTS

1 Executive summary

2 Asia-Pacific cancer screening market – market overview

3 India cancer screening market

4 China cancer screening market

5 Others (the rest of Asia-Pacific) cancer screening market

6 Competitive landscape

7 Conclusion

8 Appendix

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia Pacific Cancer Screening Market Projected to Reach US$32.26 Billion at 17.3% CAGR Till 2023 | Key Players - Abbott diagnostics, GE healthcare, Hologic, Siemens, Thermo Fisher Scientific here

News-ID: 1476969 • Views: 279

More Releases from Business Industry Reports

2020-2025 Neoantigen Targeted Therapies Market to witness astonishing growth wit …
Global Neoantigen Targeted Therapies Market Synopsis: The report covers a forecast and an analysis of the Neoantigen Targeted Therapies Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Neoantigen Targeted Therapies Market along with the impact they have
Outstanding Scope of Nasojejunal Tube Market is Estimated to Grow Incredible CAG …
Overview of Global Nasojejunal Tube Market: This report provides in-depth study of “Global Nasojejunal Tube Market 2020” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Nasojejunal Tube Market report also provides an in-depth survey of key players in the market organization. The 'Global Nasojejunal Tube Industry, Market Research Report' is a professional and in-depth study on the current state of the global Nasojejunal Tube Market with a
Huge Investment in mTOR Inhibitors Market Expected to Witness the Highest Growth …
Global mTOR Inhibitors Market Synopsis: The exclusive research report on the Global mTOR Inhibitors Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global mTOR Inhibitors Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. According to the market research study, Mammalian Target Of Rapamycin (mTOR) is
SWOT Analysis of mRNA Treatment Market Excessive Growth Opportunities Estimated …
The exclusive research report on the Global mRNA Treatment Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global mRNA Treatment Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Overview of Global mRNA Treatment Market: This report studies the Global mRNA Treatment Market over the forecast

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and